• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months.欧洲首例 2019 冠状病毒病疫情中的嗅觉丧失:8 个月后的功能恢复。
J Laryngol Otol. 2021 Mar;135(3):224-228. doi: 10.1017/S0022215121000670. Epub 2021 Feb 26.
2
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.长期 COVID-19 相关嗅觉丧失的嗅上皮组织病理学发现。
J Laryngol Otol. 2020 Dec;134(12):1123-1127. doi: 10.1017/S0022215120002455. Epub 2020 Nov 16.
3
Delayed recovery from severe acute respiratory syndrome coronavirus-2 related anosmia predicts incomplete olfactory restoration.严重急性呼吸综合征冠状病毒 2 相关嗅觉丧失的恢复延迟预示着嗅觉不能完全恢复。
J Laryngol Otol. 2022 Mar;136(3):237-242. doi: 10.1017/S0022215121004047. Epub 2021 Dec 13.
4
The outcome of olfactory impairment in patients with otherwise paucisymptomatic coronavirus disease 2019 during the pandemic.大流行期间其他症状较轻的 2019 冠状病毒病患者嗅觉障碍的转归。
J Laryngol Otol. 2021 May;135(5):426-435. doi: 10.1017/S0022215121001110. Epub 2021 Apr 22.
5
Olfactory dysfunction at six months after coronavirus disease 2019 infection.新冠病毒感染 6 个月后的嗅觉功能障碍。
J Laryngol Otol. 2021 Sep;135(9):839-843. doi: 10.1017/S0022215121002085. Epub 2021 Aug 5.
6
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.成年 SARS-CoV-2 感染患者新发嗅觉丧失和味觉丧失。
Clin Microbiol Infect. 2020 Sep;26(9):1236-1241. doi: 10.1016/j.cmi.2020.05.026. Epub 2020 Jun 2.
7
Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study.COVID-19 相关嗅觉丧失的鼻腔皮质类固醇治疗效果:一项随机双盲安慰剂对照研究。
Am J Otolaryngol. 2021 Sep-Oct;42(5):103033. doi: 10.1016/j.amjoto.2021.103033. Epub 2021 Apr 7.
8
Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia.新型冠状病毒感染后嗅觉丧失患者疾病严重程度与血清 IL-6 水平的关系。
Am J Otolaryngol. 2021 Jan-Feb;42(1):102796. doi: 10.1016/j.amjoto.2020.102796. Epub 2020 Oct 28.
9
Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study.COVID-19 患者嗅觉障碍的早期恢复模式:一项临床队列研究。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102725. doi: 10.1016/j.amjoto.2020.102725. Epub 2020 Sep 14.
10
Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.新型冠状病毒肺炎患者嗅觉障碍:嗅觉恢复的患病率和预后。
Otolaryngol Head Neck Surg. 2021 Jan;164(1):82-86. doi: 10.1177/0194599820943530. Epub 2020 Jul 14.

引用本文的文献

1
Effects of Intratympanic Steroid Therapy in Sudden Hearing Loss in Children: The Clinical Case of an Exceptionally Late Hearing Recovery.鼓室内注射类固醇疗法对儿童突发性听力损失的影响:一例极其延迟听力恢复的临床病例
Iran J Otorhinolaryngol. 2025;37(4):221-226. doi: 10.22038/ijorl.2025.83020.3794.
2
High prevalence of long-term olfactory disorders in healthcare workers after COVID-19: A case-control study.新冠疫情后医护人员长期嗅觉障碍高发:一项病例对照研究。
PLoS One. 2024 Jul 1;19(7):e0306290. doi: 10.1371/journal.pone.0306290. eCollection 2024.
3
Neurological complications after COVID-19: A narrative review.新型冠状病毒肺炎后的神经系统并发症:一篇叙述性综述。
eNeurologicalSci. 2023 Nov 15;33:100485. doi: 10.1016/j.ensci.2023.100485. eCollection 2023 Dec.
4
Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.由 SARS-CoV-2 引起的中枢神经系统损伤的表现和机制。
Brain Res Bull. 2021 Dec;177:155-163. doi: 10.1016/j.brainresbull.2021.09.015. Epub 2021 Sep 24.
5
Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers.新冠引起的嗅觉和味觉障碍可持续长达 7 个月:一项超过 700 名医护人员的研究。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab038.

欧洲首例 2019 冠状病毒病疫情中的嗅觉丧失:8 个月后的功能恢复。

Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months.

机构信息

Department of Otolaryngology, Columbus Clinic Center, Milan, Italy.

出版信息

J Laryngol Otol. 2021 Mar;135(3):224-228. doi: 10.1017/S0022215121000670. Epub 2021 Feb 26.

DOI:10.1017/S0022215121000670
PMID:33632353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7948101/
Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus-2 is a formidable virus, responsible for coronavirus disease 2019 and endowed with marked neurotropism. The damage it causes to the nervous system is manifold. The main neurological manifestation is anosmia. Olfactory damage is often transient, but there are no data reflecting an observational period of several months.

OBJECTIVE

This study evaluated the trend of anosmia in patients affected by coronavirus disease 2019 in the eight months following diagnosis.

METHODS

Fifty-five subjects who presented with symptoms suggestive of coronavirus disease 2019 and who developed anosmia, between the end of February and the beginning of March 2020, were investigated. The patients were interviewed after eight months to determine functional recovery and assess the degree of recovery.

RESULTS

Ninety-one per cent of the population reported olfactory recovery and, of these, 53 per cent had total recovery after eight months. Females and younger age groups seem slightly advantaged in functional recovery. The elderly population appears to have excellent prospects for full functional recovery.

CONCLUSION

Anosmia represents a frequent neurological manifestation during coronavirus disease 2019. Fortunately, it is transient in most cases, and only a small percentage of patients affected by it report long-term functional deficits.

摘要

背景

严重急性呼吸综合征冠状病毒 2 是一种强大的病毒,它引发了 2019 年冠状病毒病,并具有明显的嗜神经性。它对神经系统造成的损害是多方面的。主要的神经系统表现为嗅觉丧失。嗅觉损伤通常是短暂的,但没有反映观察期为几个月的数据。

目的

本研究评估了诊断后 8 个月内感染 2019 年冠状病毒病患者的嗅觉丧失趋势。

方法

对 2020 年 2 月底至 3 月初出现 2019 年冠状病毒病症状并出现嗅觉丧失的 55 名患者进行了调查。在 8 个月后对患者进行了访谈,以确定功能恢复情况并评估恢复程度。

结果

91%的患者报告嗅觉恢复,其中 53%的患者在 8 个月后完全恢复嗅觉。女性和年龄较小的群体在功能恢复方面似乎略有优势。老年人群似乎有很好的完全功能恢复前景。

结论

嗅觉丧失是 2019 年冠状病毒病期间常见的神经系统表现。幸运的是,在大多数情况下它是短暂的,只有一小部分受其影响的患者报告存在长期的功能缺陷。